You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

cytogenetic status

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Lymphocytic Leukemia (CLL) Trial

Completed
  • Chronic Lymphocytic Leukemia (CLL)
    • (no location specified)
    Apr 5, 2022

    Acute Myeloid Leukemia Trial in Worldwide (Pracinostat, Placebos, Azacitidine)

    Terminated
    Has Results
    • Acute Myeloid Leukemia
    • Phoenix, Arizona
    • +137 more
    Mar 9, 2022

    Leukemia, Myeloid, Acute, MDS Trial in Worldwide (Azacitidine, Durvalumab)

    Active, not recruiting
    Has Results
    • Leukemia, Myeloid, Acute
    • Myelodysplastic Syndromes
    • New Haven, Connecticut
    • +94 more
    Jun 9, 2022

    Acute Myeloid Leukemia Trial in Pittsburgh (mitoxantrone + etoposide + gemtuzumab ozogamicin)

    Recruiting
    • Acute Myeloid Leukemia
    • mitoxantrone + etoposide + gemtuzumab ozogamicin
    • Pittsburgh, Pennsylvania
      UPMC Hillman Cancer Center
    Feb 9, 2022

    Venetoclax Plasma Concentration and Remission in Acute Myeloid

    Not yet recruiting
    • Adult Acute Myeloid Leukemia
    • Blood sampling for venetoclax drug dosage (venous puncture)
    • (no location specified)
    Sep 13, 2023

    Microchimeric Cell Tranfer From Mother to Child - Pilo Study

    Recruiting
    • Breastfeeding
      • Montpellier, France
        Uh Montpellier
      Feb 10, 2022

      Myelodysplastic/Myeloproliferative Tumors, Adult Trial in Suzhou (venetoclax combined with azacitidine)

      Enrolling by invitation
      • Myelodysplastic/Myeloproliferative Neoplasms
      • Adult
      • venetoclax combined with azacitidine
      • Suzhou, Jiangsu, China
        The First Affiliated Hospital of Soochow University, Jiangsu Ins
      Mar 7, 2022

      Myelodysplastic Syndrome, Secondary Acute Myeloid Leukemia Trial in Tours (Samples, Quality of life questionnaire)

      Completed
      • Myelodysplastic Syndrome
      • Secondary Acute Myeloid Leukemia
      • Samples
      • Quality of life questionnaire
      • Tours, France
      • +1 more
      Apr 15, 2021

      According to Molecular Identification at Diagnosis

      Not yet recruiting
      • Chronic Myeloid Leukemia
      • Next Generation Sequencing (DNA and RNA)
      • (no location specified)
      Oct 28, 2022

      Recurrent Chronic Myelomonocytic Leukemia, Refractory Chronic Myelomonocytic Leukemia Trial in Rochester (Biospecimen

      Recruiting
      • Recurrent Chronic Myelomonocytic Leukemia
      • Refractory Chronic Myelomonocytic Leukemia
      • Biospecimen Collection
      • +3 more
      • Rochester, Minnesota
        Mayo Clinic in Rochester
      Jan 4, 2023

      Fetal Growth Retardation Trial in New York (Fetal Genome Profiling.)

      Recruiting
      • Fetal Growth Retardation
      • Fetal Genome Profiling.
      • New York, New York
        Weill Cornell Medicine
      Jul 27, 2022

      Chronic Lymphocytic Leukemia Trial in Russian Federation

      Recruiting
      • Chronic Lymphocytic Leukemia
        • Irkutsk, Russian Federation
        • +5 more
        Jan 17, 2023

        A Study of Real Life Treatment for Multiple Myeloma (MM)

        Active, not recruiting
        • Multiple Myeloma
          • Astrakhan, Russian Federation
          • +28 more
          Apr 14, 2022

          Secondary Myelodysplastic Syndrome, Therapy-Related Myelodysplastic Syndrome Trial in Columbus (Azacitidine, Quality-of-Life

          Recruiting
          • Secondary Myelodysplastic Syndrome
          • Therapy-Related Myelodysplastic Syndrome
          • Columbus, Ohio
            Ohio State University Comprehensive Cancer Center
          Dec 1, 2022

          Leukemia, Myeloid, Acute Trial in Portugal, Spain (Pevonedistat, Azacitidine)

          Active, not recruiting
          • Leukemia, Myeloid, Acute
          • Coimbra, Portugal
          • +63 more
          Sep 9, 2022

          Prognosis of AML Patients According to Routinely Used Genetic

          Completed
          • Acute Myeloid Leukemia
            • Albacete, Spain
            • +21 more
            Sep 12, 2022

            Newly Diagnosed Multiple Myeloma Trial in New York (Daratumumab, Bortezomib, Lenalidomide)

            Recruiting
            • Newly Diagnosed Multiple Myeloma
            • New York, New York
              Icahn School of Medicine at Mount Sinai
            Dec 29, 2022

            People With Multiple Myeloma in Portugal

            Recruiting
            • Relapse and/or Refractory Multiple Myeloma
              • Braga, Portugal
              • +7 more
              Jun 9, 2022

              Acute Lymphoblastic Leukemia Trial in Houston (Blinatumomab, Hematopoietic Cell Transplantation)

              Completed
              Has Results
              • Acute Lymphoblastic Leukemia
              • Houston, Texas
                University of Texas MD Anderson Cancer Center
              Dec 30, 2022

              CharactHer. ICORG 12-09, V3

              Terminated
              • HER2-positive Breast Cancer
              • TNM Stage II-IV Breast Cancer
                • Dublin, Ireland
                • +1 more
                Jan 14, 2022

                Multiple Myeloma Trial in Tianjin (Autologous hematopoietic stem cell transplantation, C-CAR088)

                Recruiting
                • Multiple Myeloma
                • Autologous hematopoietic stem cell transplantation
                • C-CAR088
                • Tianjin, Tianjin, China
                  Institute of Hematology & Blood Diseases Hospital
                Nov 21, 2022

                Adverse Childhood Experiences, Adaptation and Breast Cancer

                Recruiting
                • Adverse Childhood Experiences
                • +5 more
                • Biological and epigenetic measures
                • Metz, Lorraine, France
                  Ur 4360 Apemac
                Apr 24, 2023

                AML, MDS, ALL, Adult Trial in Hackensack, New York (SOC + TSC-100, SOC + TSC-101, Control)

                Recruiting
                • AML
                • +2 more
                • SOC + TSC-100
                • +2 more
                • Hackensack, New Jersey
                • +1 more
                Aug 11, 2022

                Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma Trial in

                Recruiting
                • Recurrent B-Cell Non-Hodgkin Lymphoma
                • +13 more
                • Polatuzumab Vedotin
                • +3 more
                • Scottsdale, Arizona
                • +11 more
                Aug 23, 2022

                Chronic Myeloid Leukemia Trial in Worldwide (Omacetaxine mepesuccinate)

                Completed
                Has Results
                • Chronic Myeloid Leukemia
                • Omacetaxine mepesuccinate
                • Los Angeles, California
                • +28 more
                Dec 1, 2021